EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia


American Journal of Cardiology 62(9): 585-589
Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia
The antiarrhythmic effects of flecaininde acetate were evaluated in 9 patients with paroxysmal atrioventricular(AV) nodal tachycardia and 17 patients with AV tachycardia. An electrophysiologic study was performed before and after intravenous flecainide acetate, 2 mg/kg body weight, was infused over 15 minutes and was followed by a maintenance infusion of 1.6 mg/kg given over 1 hour to 26 patients and during oral treatment to 15. Treatment with oral flecaininde acetate was continued for 14 .+-. 5 months. Intravenous flecainide acetate terminated AV nodal tachycardia by blocking the retrograde fast pathway conduction in 7 of 7 patients and AV tachycardia by blocking retrograde conduction in the extranodal pathway in 10 of 10 patients. AV nodal tachycardia and AV tachycardia were noninducible in 8 of 9 patients (90%, p < 0.001) and 11 of 17 patients (65%, p .+-. 0.001), respectively. Long-term treatment with oral flecaininde acetate suppressed AV nodal tachycardia and AV tachycardia in 8 of 9 patients (90%, p < 0.001) and 11 of 17 patients (65%, p < 0.001), respectively. A favorable outcome was associated with block in the accessory pathway after intravenous flecainide acetate and noninducibility during oral treatment. Recurrences preferentially occurred in the younger patients. Flecainide acetate is effective in the acute and long-term management of paroxysmal supraventricular reentry tachyacardia by suppressing conduction through the retrograde fast limb of the tachycardia circuit. The clinical effect can be predicted by electrophysiologic testing.

Accession: 005349242

PMID: 3137798

DOI: 10.1016/0002-9149(88)90660-1

Download PDF Full Text: Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia



Related references

Electrophysiologic effects and clinical efficacy of flecainide f in children with recurrent paroxysmal supraventricular tachycardia pst. European Heart Journal 8(ABSTR SUPPL 2): 194, 1987

Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. American Journal of Cardiology 62(4): 229-233, 1988

Electrophysiologic effects and clinical efficacy of flecainide in pediatric patients with recurrent paroxysmal supraventricular tachycardia. Giornale Italiano di Cardiologia 17(5): 444-449, 1987

Electrophysiologic effects and clinical efficacy of propafenone p in children with recurrent paroxysmal supraventricular tachycardia pst. European Heart Journal 8(ABSTR SUPPL 2): 97, 1987

Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. Journal of the American College of Cardiology 17(2): 297-303, 1991

Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Indian Heart Journal 47(3): 237-243, 1995

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation 83(1): 119-125, 1991

Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group. American Journal of Cardiology 74(6): 578-584, 1994

Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia. Giornale Italiano di Cardiologia 17(5): 444-449, 1987

Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia. Indian Heart Journal 46(3): 141-144, 1994